Kane Biotech (TSE:KNE) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Kane Biotech has secured its first distribution agreement in the Middle East, partnering with Razan Medical Trading to bring its revyve™ Antimicrobial Wound Gel to the United Arab Emirates’ wound care market. This marks the company’s third distribution deal, following previous agreements in the US and parts of Latin America, showcasing its commitment to expanding commercialization on a global scale.
For further insights into TSE:KNE stock, check out TipRanks’ Stock Analysis page.